Mounjaro Vs Wegovy In The UK: Dosing And Cost Comparison

Choosing between two prescription injections in the UK involves more than checking the advertised monthly price. Dosing steps, pen format, prescribing r...

Choosing between two prescription injections in the UK involves more than checking the advertised monthly price. Dosing steps, pen format, prescribing rules, and how each medicine affects appetite can all change the day-to-day experience. This guide explains the practical differences between Mounjaro and Wegovy in clear, fact-based terms for UK readers.

For many adults in the UK, the main question is not whether these medicines are taken often, because both are usually used as a weekly injection, but how their dosing plans, side effects, prescribing checks, and private pricing differ in real life. Mounjaro contains tirzepatide, while Wegovy contains semaglutide, and both are prescribed as part of a broader approach to obesity management that may also include diet, physical activity, and follow-up reviews. In practice, the better fit often depends on tolerability, medical history, and how straightforward the dose escalation feels over time.

This article is for informational purposes only and should not be considered medical advice. Please consult a qualified healthcare professional for personalized guidance and treatment.

How weekly dosing usually works

The dosing schedules are similar in structure but different in strength steps. Mounjaro is commonly started at 2.5 mg once weekly for four weeks, then increased to 5 mg, with later increases in 2.5 mg steps if needed and tolerated. Wegovy usually starts at 0.25 mg once weekly and then moves through 0.5 mg, 1 mg, 1.7 mg, and 2.4 mg at roughly four-week intervals. In both cases, dose escalation is designed to reduce side effects, so a prescriber may slow the schedule if nausea or digestive symptoms become difficult.

Prescription rules in the UK

Both medicines are prescription-only in the UK, so they should not be viewed as standard retail products. A pharmacy or clinic will usually assess body mass index, medical history, current medicines, and whether there are conditions that affect safe prescribing. NHS access and private access are not the same, and local pathways can differ. Private services often use online questionnaires, identity checks, and sometimes photo or weight verification before issuing a prescription. That means convenience varies by provider, but clinical screening remains an important part of the process.

Appetite and expected differences

A major reason people compare these treatments is appetite control. Both medicines act on hormone pathways linked to hunger, fullness, and food intake, so people often report feeling satisfied sooner and thinking about food less often. Mounjaro targets both GIP and GLP-1 receptors, while Wegovy targets GLP-1 receptors. That difference is one reason the comparison receives so much attention, but individual response still varies. Some people focus on stronger appetite suppression, while others care more about tolerability, bowel side effects, or how easy it is to stay consistent with a weekly routine.

Real-world pricing from pharmacy and clinic

Cost in the UK can be harder to compare than the headline monthly figure suggests. Private pricing usually changes by dose strength, and some providers include prescribing support, needles, delivery, or follow-up check-ins, while others separate those costs. In general, lower starter doses tend to be cheaper than higher maintenance doses. Typical private pricing often places Mounjaro at roughly £130 to £300 for a four-week supply and Wegovy at roughly £150 to £300, but the exact amount depends on provider, stock, and what the service bundle includes.

Prices, rates, or cost estimates mentioned in this article are based on the latest available information but may change over time. Independent research is advised before making financial decisions.

Pen format and practical use

The pen matters more than many first-time users expect. In UK supply channels, both treatments are typically provided in pen-based injection formats intended for once-weekly self-administration, but the handling process, needle fitting, storage, and dose progression can still feel different. A pharmacy or clinic should explain how to use the pen correctly, where to inject, and how to store it before and after first use. For some people, practical details such as travelling with the pen, remembering a weekly day, or managing missed doses are just as important as the medicine name.

What matters most in a comparison

A useful comparison is not only about which medicine costs less at the start. It should also include dose progression, expected review frequency, side effect profile, and how prescribing works through a pharmacy or clinic. Someone looking closely at obesity treatment may prioritise appetite reduction, while another person may prioritise a simpler escalation plan or lower starting cost. It is also worth checking whether the quoted price covers only the injection or also includes prescription review, customer support, and replacement timing if supply is delayed.

When comparing these two options in the UK, the clearest differences are their dosing ladders, active ingredients, and the way private pricing tends to rise with higher strengths. Both are weekly prescription injections used within broader weight management care, and neither should be judged by advertised price alone. A careful comparison looks at safety screening, pen use, appetite effects, and the full monthly cost rather than a single number.